Related Articles
Relationship between adverse events associated with lenvatinib treatment for thyroid cancer and patient prognosis
Sorafenib in metastatic radioactive iodine‑refractory differentiated thyroid cancer: A pilot study
Proteomic analysis of radioiodine‑refractory differentiated thyroid cancer identifies CHI3L1 upregulation in association with dysfunction of the sodium‑iodine symporter
Predictive factors of cytotoxic damage in radioactive iodine treatment of differentiated thyroid cancer patients
Treatment outcomes of differentiated thyroid cancer with distant metastasis improve by tyrosine kinase inhibitors